R&D- Medical: Health Services (Commercialized)

The Product Service Code AN47 represents Research and Development (R&D) for Medical Health Services within the commercialized sector. This PSC category encompasses specialized medical research initiatives focused on developing and advancing health-related technologies, treatments, and service methodologies. The category covers comprehensive medical research projects that have potential commercial applications, targeting innovative solutions in healthcare delivery, medical technologies, and clinical service improvements. Projects within this category typically involve advanced scientific investigation with clear translational potential for healthcare industries and medical service enhancement.

Federal Contract Awards for AN47 demonstrate a robust pattern of research funding across multiple federal health-related agencies. Typical contract values range from $250,000 to $5 million, with performance periods spanning 12-36 months. Primary funding agencies include the National Institutes of Health (NIH), Department of Defense (DoD) medical research divisions, and the Department of Health and Human Services (HHS). Frequent award recipients include academic medical research centers, biotechnology firms, and specialized healthcare research organizations. Contract mechanisms often utilize small business set-asides, particularly for emerging medical technology development, with performance locations predominantly concentrated in major research hubs such as Boston, San Francisco, Baltimore, and Washington D.C. metropolitan areas.

No specific federal contract opportunities were provided within the submitted materials for detailed analysis. Additional research or documentation would be required to comprehensively describe current solicitations within the AN47 Product Service Code category.